Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

How Surgical Innovations Group plc (LSE:SUN) Expands Carbon Footprint Reduction Data to Win Hospital Tenders

Surgical Innovations Group plc (LSE:SUN) has highlighted recovering elective surgery volumes and expanding international demand for its specialised surgical consumables. The Yorkshire-based medical technology designer and manufacturer specializes in minimally invasive and laparoscopic surgical instruments. The company's core technological offering includes proprietary reposable surgical …

Ankur Sharma | 14 October 2026

What Futura Medical plc (LSE:FUM) Revealed Regarding Supply Chain Scalability for Global Eroxon Shipments

Futura Medical plc (LSE:FUM) has advanced its transition from a clinical-stage R&D organisation into a revenue-generating commercial healthcare enterprise. The company focuses on the global commercialisation of its proprietary topical gel portfolio, led by Eroxon (MED3000) for erectile dysfunction. Eroxon holds a unique clinical …

Ankur Sharma | 14 October 2026

Why Genedrive plc (LSE:GDR) Prioritises Assay Cartridge Thermal Stability for Field-Deployable Genetic Testing

Genedrive plc (LSE:GDR) has continued to drive the clinical deployment of its revolutionary point-of-care pharmacogenetic testing platforms across emergency hospital settings. The Manchester-based molecular diagnostics company develops rapid, portable diagnostic instruments. Its core technological innovation enables clinical staff to conduct rapid DNA testing at …

Ankur Sharma | 14 October 2026

How Genflow Biosciences Plc (LSE:GENF) Conducts Vector Biodistribution Testing in Preclinical Fibrosis Studies

Genflow Biosciences Plc (LSE:GENF) has continued to advance its preclinical gene therapy pipeline engineered to halt or reverse the biological aging process and treat age-related degenerative diseases. The UK-headquartered biopharmaceutical enterprise is the first European-listed pure-play longevity biotechnology company. Its therapeutic approach harnesses the …

Ankur Sharma | 14 October 2026

How GSK plc (LSE:GSK) Advances Monoclonal Antibody Therapies Across Severe Asthma Patient Populations

GSK plc (LSE:GSK) has reinforced its commercial trajectory and scientific productivity following its successful corporate demerger of consumer healthcare assets, operating as a 100% dedicated global biopharmaceutical enterprise. The multinational pharmaceutical leader focuses on four core therapeutic areas: Vaccines, Specialty Medicines (HIV, Oncology, Respiratory/Immunology), …

Ankur Sharma | 14 October 2026

How HemoGenyx Pharmaceuticals Plc (LSE:HEMO) Validates In Vitro Cytotoxicity Assays for Acute Myeloid Leukaemia Therapies

HemoGenyx Pharmaceuticals Plc (LSE:HEMO) has maintained clinical momentum across its innovative cell therapy and biopharmaceutical pipeline targeting lethal hematologic malignancies and blood disorders. The biopharmaceutical development enterprise utilizes advanced cellular engineering and synthetic biology to address profound unmet clinical needs in leukemia. The company's …

Ankur Sharma | 14 October 2026

Why Hikma Pharmaceuticals Plc (LSE:HIK) Expands High-Potency Injectable Manufacturing Infrastructure

Hikma Pharmaceuticals PLC (LSE:HIK) has reinforced its market leadership across critical global pharmaceutical sectors through the disciplined execution of its three-pillar operating model: Injectables, Generics, and Branded medicines. The multinational pharmaceutical company manufactures and distributes high-quality generic and specialty pharmaceutical products. The group's primary …

Ankur Sharma | 14 October 2026

How Haleon plc (LSE:HLN) Optimises Pain Relief Portfolio Manufacturing Across Global Distribution Hubs

Haleon plc (LSE:HLN) has continued to demonstrate steady organic revenue growth and expanding operating profit margins across its global consumer healthcare footprint. The multinational healthcare leader operates as a 100% focused consumer self-care corporation following its historic demerger from GSK. The company commands unmatched …

Ankur Sharma | 14 October 2026

How Inspiration Healthcare Group PLC (LSE:IHC) Manages Component Procurement Lead Times for Complex Ventilator Assemblies

Inspiration Healthcare Group PLC (LSE:IHC) has focused executive attention on restructuring its international commercial distribution model and optimizing inventory management across its neonatal intensive care portfolio. The medical technology enterprise develops, manufactures, and distributes innovative medical devices for neonatal intensive care units (NICUs) and …

Ankur Sharma | 14 October 2026

How ImmuPharma plc (LSE:IMM) Prepares Regulatory Briefing Dossiers for P140 Subcutaneous Dosing

ImmuPharma plc (LSE:IMM) has continued to advance the clinical development and intellectual property estate surrounding its lead therapeutic programme, P140, across major international pharmaceutical jurisdictions. The specialist drug discovery and biopharmaceutical development enterprise focuses on peptide-based therapies targeting chronic autoimmune conditions. The company's flagship …

Ankur Sharma | 14 October 2026
Support

Hi! How can we help you today?

Loading…